Enhanced CAR T-Cell Therapy Shows Promise in Treating B-Cell Cancers
Audio narration · Coming soon
A phase I clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. has reported promising results for an enhanced CAR T-cell therapy targeting B-cell cancers. This development marks a potential advancement in immunotherapy for these types of cancers.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews